GLMD - Galmed Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 11 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 46.67% of the time, taking 604 days on average.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 24-Jul-2023. First documented stock forecast 28-Mar-2016.

Best performing analysts who are covering GLMD - Galmed Pharmaceuticals Ltd:

Jason Kolbert Edward Nash Jason Mccarthy Adam Walsh Ed Arce

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Jul-2023

3 years 3 months 29 days ago
(24-Jul-2023)

1/3 (33.33%)

$2383.2 (96.22%)

89

Buy Since 12-Jun-2018

$180

4 years 3 months 14 days ago
(08-Aug-2022)

0/2 (0%)

$98.89 (121.92%)

Hold Since 18-May-2022

4 years 6 months 4 days ago
(18-May-2022)

1/2 (50%)

$4573.8 (144.46%)

2101

Buy Since 13-Jul-2018

$375

6 years 6 months 8 days ago
(14-May-2020)

1/2 (50%)

$-539.4 (-58.99%)

581

Buy Since 24-Mar-2017

8 years 8 months 7 days ago
(15-Mar-2018)

2/2 (100%)

$1251 (98.58%)

249

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 604 days for the stock forecasts to be reached, with an average price target met ratio of 46.67%.

Which analyst most recently updated their price target on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Mccarthy

Which analyst has the lowest performance score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Mccarthy works at MAXIM GROUP and has 3 price targets and 3 ratings on GLMD

Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?

Adam Walsh with the highest potential upside of $371.38

Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?

Jason Kolbert with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?